HTG MOLECULAR DIAGNOSTICS IN's ticker is and the CUSIP is 40434H302. A total of 13 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HighMark Wealth Management LLC | 580 | $2,314 | 0.00% |
Tower Research Capital LLC (TRC) | 6,689 | $27 | 0.00% |
ROYAL BANK OF CANADA | 4 | $0 | 0.00% |
Allworth Financial LP | 277 | $1,105 | 0.00% |
TCI Wealth Advisors, Inc. | 2 | $8 | 0.00% |
UBS Group AG | 1,975 | $7,880 | 0.00% |
WELLS FARGO & COMPANY/MN | 4 | $16 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MORGAN STANLEY | 884 | $3,527 | 0.00% |
BlackRock Inc. | 6,104 | $24,355 | 0.00% |